Effects of liraglutide on the differentiation of human bone marrow mesenchymal stem cells into insulin producing cells
10.3760/cma.j.issn.1000-6699.2012.05.014
- VernacularTitle:利拉鲁肽在人骨髓间充质干细胞诱导分化为胰岛素分泌细胞中的作用
- Author:
Pin CHEN
;
Fangfang ZHANG
;
Huiling WANG
;
Xiangjin XU
- Publication Type:Journal Article
- Keywords:
Human bone marrow mesenchymal stem cells;
Liraglutide;
Induction;
Differentiation;
Insulin producing cells
- From:
Chinese Journal of Endocrinology and Metabolism
2012;28(5):414-418
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the effects of liraglutide on the differentiation of human bone marrow mesenchymal stem cells (hBM-MSCs) into insulin-producing cells (IPCs).MethodsIn vitro,hBM-MSCs were induced into IPCs by three-stage induction procedure containing high glucose,nicotinamide,and liraglutide.The morphological change of cells was observed by inverted microscope during induction and the induced cells were confirmed by dithizone(DTZ) staining.The protein expressions of pancreatic and duodenal homeobox-1 (PDX-1),glucose transporter 2 (GLUT2),glucokinase(GK),and insulin in each stage of the induced cells were detected by Western blot.Insulin secretion was measured by ELISA.ResultsThe induced effect was pronounced after adding 10 nmol/L liraglutide for 7 days.Cells began to aggregate and get round gradually during induction,and the morphology of most cells appeared as grape-like aggregation and clustered islet-like cells by the end of induction.The number of DTZ positive cells and the protein expressions of PDX-1,GLUT2,GK,and insulin were increased gradually( P＜0.05 ).The basal and glucose-stimulated insulin secretion from induced cells was also increased gradually(P＜0.05).Conclusion BM-MSCs could be induced into IPCs by high glucose,nicotinamide,and liraglutide in vitro.
